ESGCT 2023

The ESGCT Congress brings together leading gene and cell therapy scientists. We’re excited to get immersed in the latest research and scientific advances, and connect with experts like you from Europe and beyond.

Even more important, we’re looking forward to talking in more detail about your upcoming projects, and discussing ways that we can work together to help you advance cell therapy.

Registration has ended for this event.

We’re also presenting two posters at the congress; take a look to gain some insight into our advances in AAV gene therapy.

Ncardia Posters at ESGCT

• P289 Evaluating the transduction efficiency of different AAV serotypes on hiPSC-derived cardiomyocytes
• P285 Human induced pluripotent stem cell-derived models as a platform to advance AAV testing with high confidence